Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
about
Parvovirus minute virus of mice induces a DNA damage response that facilitates viral replicationChk2 activation dependence on Nbs1 after DNA damageTrans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchangeMDC1 is a mediator of the mammalian DNA damage checkpointTAO kinases mediate activation of p38 in response to DNA damageThe stress kinase MRK contributes to regulation of DNA damage checkpoints through a p38gamma-independent pathwayIncreased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanismHuman PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiationRAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylationInteraction between human MCM7 and Rad17 proteins is required for replication checkpoint signalingChk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genesRegulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379The cohesin complex is required for the DNA damage-induced G2/M checkpoint in mammalian cellsThe DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replicationThe mismatch repair system is required for S-phase checkpoint activationVaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damagePolo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbodyInvolvement of human MOF in ATM functionATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppressionArtemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint responseHuman Claspin works with BRCA1 to both positively and negatively regulate cell proliferationNutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrolUltrasensitivity in the Regulation of Cdc25C by Cdk1Irofulven induces replication-dependent CHK2 activation related to p53 statusStudy design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE studyMutation analysis of the CHK2 gene in breast carcinoma and other cancersThe associations between Parkinson's disease and cancer: the plot thickensHydrogen peroxide - production, fate and role in redox signaling of tumor cellsDNA damage signaling assessed in individual cells in relation to the cell cycle phase and induction of apoptosisInvolvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ)Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptationCrystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitorStructural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapyFragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancerReplication fork instability and the consequences of fork collisions from rereplicationFunctional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia-mutated protein, ATMMammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways
P2860
Q21131433-D5F1E1B4-ACE3-4897-86B6-B874E1903DA8Q24291406-FD690482-4DCC-4A5C-8FEA-C083D3861E09Q24294605-DE1E6DBB-0C47-471B-AFFA-A2090D1CAB37Q24296229-F3C21061-5F60-4FC5-94B1-3989AFD57C24Q24301324-8FED24BA-517A-43AB-A588-51A9F92EEF81Q24302278-4F8A1386-D492-4180-AB33-D8BAE1209D11Q24305585-7A03C42F-422E-47F7-B565-211DA13A3F75Q24305756-39D09D28-7061-461E-9DAD-64B9CF6ED766Q24311792-9C704F2F-82EA-4FD3-BA4F-6D833183CC69Q24314203-A68C70B8-D272-4858-9B1C-317B234167A6Q24314901-E744C5A6-1986-425D-A7A9-B380B0B61187Q24315969-22FC34F2-8CE2-4D66-B593-671FD366D33DQ24317260-A14ADDB5-3186-4B25-B1DE-12D2F02CC5DDQ24318659-A666FD74-51F2-466B-8FAB-66428C6A54A0Q24321503-5C52CDF3-3D27-4668-806B-22994568A8D4Q24336079-4229041B-88DE-49C1-A20A-BBC0080B839BQ24337413-D0A629C2-B074-4F4B-9DCE-7DA7D476B4DAQ24529072-3F64885A-FF11-43B5-9571-89E2F4183084Q24550952-50E12BF5-122A-42E1-A98A-E581C472EC4AQ24556572-C716904A-D992-4C91-AF38-A0C06689494EQ24557573-1DC4AF7B-F44C-4340-A3E9-D99BEF67818BQ24561444-49AC225B-E19F-4795-82CE-A00A059B8CB9Q24564847-F3AB5F05-0BD2-4972-B30D-5CDE834D83CFQ24595171-3FBDAB01-BECB-41B3-96F8-10B0FCAD8D52Q24633843-3EB04C71-1A99-4E45-9959-874BFE6FF695Q24673564-ACA71632-1BE8-46C3-B960-BA54F6C88BB0Q24794680-3349064C-77F9-4CD8-B389-016EDA95CDD9Q24807365-15567D8B-3C49-43B1-990A-D5E072ED1980Q26778641-A00DB64A-CA87-4295-8B11-0A297DFBB2DFQ26787065-C2F7B335-6168-4FD8-AE11-EF0411C6B934Q26822413-8B9F7EEA-EE03-4D78-87B8-6ED98C24A6ACQ27002581-FDEF37D4-9411-4988-86E7-698BEF9BDEDCQ27026117-70640154-A201-43CC-8466-E5C7A5241CF2Q27653589-E42EFACB-5E8A-4E40-A1FE-1CFE3963A8D7Q27674646-337E7EC1-0146-4622-A742-690F58CC0E06Q27678684-7A556AC5-2753-4E29-9651-36CD7785B717Q28066320-01238084-D4EC-4015-ADE6-6E3F1F3893D5Q28076969-CB80614E-AFFF-41D2-8028-736B1D34CD0EQ28201174-73A0D3EB-F202-43E5-9E68-1DF3E041A6C1Q28202838-034A7187-32E8-4BB9-B51E-E79610279C95
P2860
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@ast
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@en
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@nl
type
label
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@ast
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@en
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@nl
prefLabel
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@ast
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@en
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@nl
P2093
P2860
P3181
P356
P1476
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
@en
P2093
P2860
P304
P3181
P356
10.1073/PNAS.190030497
P407
P577
2000-09-12T00:00:00Z